[Management of spasticity in children with cerebral palsy]
- PMID: 19448346
- DOI: 10.3944/AOTT.2009.081
[Management of spasticity in children with cerebral palsy]
Abstract
Management of spasticity is a major challenge to the rehabilitation team. The initial management has centered on the elimination of externally exacerbating causes, physical therapy, splinting and casting. Medical management has centered on anti-spasticity medication use, but more recently focal treatment methods including phenol blocks and botulinum toxin have been utilized. There has been an increased use of intrathecal baclofen in the management of refractory tone. Dorsal rhizotomy has been advocated for a selective population of children with spasticity. There is no standardized approach to spasticity management and this paper will discuss the importance of evidence-based treatment of spasticity that is adapted for the individual child.
Similar articles
-
Therapeutic interventions for tone abnormalities in cerebral palsy.NeuroRx. 2006 Apr;3(2):217-24. doi: 10.1016/j.nurx.2006.01.008. NeuroRx. 2006. PMID: 16554259 Free PMC article. Review.
-
Management of spasticity in children with cerebral palsy.Semin Pediatr Neurol. 2009 Jun;16(2):82-9. doi: 10.1016/j.spen.2009.03.006. Semin Pediatr Neurol. 2009. PMID: 19501336 Review.
-
Pharmacotherapy of spasticity: oral medications and intrathecal baclofen.J Child Neurol. 2001 Jan;16(1):31-6. doi: 10.1177/088307380101600106. J Child Neurol. 2001. PMID: 11225954 Review.
-
[Clinical treatment (non surgical) of spasticity in cerebral palsy].Rev Neurol. 2002 Jan 1-15;34(1):1-6. Rev Neurol. 2002. PMID: 11988886 Review. Spanish.
-
New approaches to managing spasticity in children with cerebral palsy.West J Med. 1997 Apr;166(4):271. West J Med. 1997. PMID: 9168686 Free PMC article. No abstract available.
Cited by
-
Management of spasticity in children with cerebral palsy.Iran J Pediatr. 2014 Aug;24(4):345-51. Epub 2014 May 9. Iran J Pediatr. 2014. PMID: 25755853 Free PMC article. Review.
-
Multilevel botulinum toxin type a as a treatment for spasticity in children with cerebral palsy: a retrospective study.Clinics (Sao Paulo). 2010 Jun;65(6):613-9. doi: 10.1590/S1807-59322010000600009. Clinics (Sao Paulo). 2010. PMID: 20613938 Free PMC article.
-
Exploratory study on the ayurvedic therapeutic management of cerebral palsy in children at a tertiary care hospital of karnataka, India.J Tradit Complement Med. 2014 Jan;4(1):49-55. doi: 10.4103/2225-4110.124345. J Tradit Complement Med. 2014. PMID: 24872933 Free PMC article.
-
In Support of Initial Parenteral Medical Management of Intrathecal Baclofen Withdrawal in Spasticity Patients.J Pharm Technol. 2021 Dec;37(6):293-297. doi: 10.1177/87551225211039237. Epub 2021 Aug 12. J Pharm Technol. 2021. PMID: 34790966 Free PMC article.
-
The effect of postural control and balance on femoral anteversion in children with spastic cerebral palsy.J Phys Ther Sci. 2016 Jun;28(6):1696-700. doi: 10.1589/jpts.28.1696. Epub 2016 Jun 28. J Phys Ther Sci. 2016. PMID: 27390397 Free PMC article.